SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$13.3B
1-Year Return
26.83%
This Quarter Return
+8.14%
1 Year Return
+26.83%
3 Year Return
+97.05%
5 Year Return
+189.63%
10 Year Return
–
AUM
$2.25B
AUM Growth
+$404M
(+22%)
Cap. Flow
+$302M
Cap. Flow
% of AUM
13.45%
Top 10 Holdings %
Top 10 Hldgs %
14.55%
Holding
1,127
New
392
Increased
185
Reduced
178
Closed
359
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$95.2M |
| 2 |
Fortive
FTV
|
$33.6M |
| 3 |
Keurig Dr Pepper
KDP
|
$22.6M |
| 4 |
GB
Global Blue Group Holding
GB
|
$21.2M |
| 5 |
Wynn Resorts
WYNN
|
$21.2M |
Top Sells
| 1 |
FPAC.U
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
|
$22.4M |
| 2 |
Equitable Holdings
EQH
|
$22.2M |
| 3 |
Sherwin-Williams
SHW
|
$21.6M |
| 4 |
Visa
V
|
$12.5M |
| 5 |
Morgan Stanley
MS
|
$12.4M |
Sector Composition
| 1 | Healthcare | 22.34% |
| 2 | Consumer Discretionary | 16.15% |
| 3 | Industrials | 13.85% |
| 4 | Technology | 11.36% |
| 5 | Financials | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Verizon
VZ
$187B
| $1.85M | 0.08% |
+34,654
| New | +$1.85M |
|
302
Valmont Industries
VMI
$7.46B
| $1.84M | 0.08% |
+13,300
| New | +$1.84M |
|
303
Harvard Bioscience
HBIO
$21.3M
| $1.84M | 0.08% |
350,600
+175,600
| +100% | +$922K |
|
304
Sensient Technologies
SXT
$4.79B
| $1.82M | 0.08% |
23,800
+20,090
| +542% | +$1.54M |
|
305
Lennox International
LII
$20.3B
| $1.81M | 0.08% |
8,300
+6,051
| +269% | +$1.32M |
|
306
Abercrombie & Fitch
ANF
$4.49B
| $1.81M | 0.08% |
85,700
+64,500
| +304% | +$1.36M |
|
307
FirstEnergy
FE
$25.1B
| $1.8M | 0.08% |
48,472
-111,467
| -70% | -$4.14M |
|
308
Globus Medical
GMED
$8.18B
| $1.8M | 0.08% |
31,700
-47,878
| -60% | -$2.72M |
|
309
Allstate
ALL
$53.1B
| $1.8M | 0.08% |
18,200
-2,398
| -12% | -$237K |
|
310
HealthEquity
HQY
$7.88B
| $1.79M | 0.08% |
19,000
+9,000
| +90% | +$850K |
|
311
Ryman Hospitality Properties
RHP
$6.35B
| $1.79M | 0.08% |
+20,800
| New | +$1.79M |
|
|
BIG
312
DELISTED
Big Lots, Inc.
BIG
| $1.78M | 0.08% |
+42,500
| New | +$1.78M |
|
313
Bristol-Myers Squibb
BMY
$96B
| $1.76M | 0.08% |
28,400
+14,149
| +99% | +$878K |
|
314
Lam Research
LRCX
$130B
| $1.71M | 0.08% |
+113,000
| New | +$1.71M |
|
315
McKesson
MCK
$85.5B
| $1.71M | 0.08% |
12,900
+8,762
| +212% | +$1.16M |
|
316
Cadence Design Systems
CDNS
$95.6B
| $1.71M | 0.08% |
37,690
+13,121
| +53% | +$595K |
|
|
LOXO
317
DELISTED
Loxo Oncology, Inc
LOXO
| $1.71M | 0.08% |
10,000
| – | – |
|
318
Autodesk
ADSK
$69.5B
| $1.7M | 0.08% |
+10,900
| New | +$1.7M |
|
319
Enovis
ENOV
$1.84B
| $1.7M | 0.08% |
+27,307
| New | +$1.7M |
|
320
NetApp
NTAP
$23.7B
| $1.69M | 0.08% |
+19,700
| New | +$1.69M |
|
321
Rockwell Automation
ROK
$38.2B
| $1.69M | 0.08% |
+9,000
| New | +$1.69M |
|
322
Establishment Labs
ESTA
$1.13B
| $1.69M | 0.08% |
+70,000
| New | +$1.69M |
|
323
Carisma Therapeutics
CARM
$16.8M
| $1.67M | 0.07% |
+38,905
| New | +$1.67M |
|
324
HEICO
HEI
$44.8B
| $1.67M | 0.07% |
+18,028
| New | +$1.67M |
|
325
Sempra
SRE
$52.9B
| $1.65M | 0.07% |
+29,040
| New | +$1.65M |
|